EGFR and neoplasm: Initial uptake studies using intratracheally administered CFSE-labelled EVs in tumor bearing mice revealed that EGFR-targeted EVs showed significantly higher levels of uptake by tumor cells as compared to untargeted EVs (Figure 6B, S11A).